AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
Keep up to date on AgNovos events and related news
During DKOU (German Congress of Orthopedic and Trauma Surgery), Dr James Howe will deliver a lecture on OSSURE LOEP technique, an emerging treatment for osteoporotic bone loss in the proximal femur.
During DKOU (German Congress of Orthopedic and Trauma Surgery) AgNovos will sponsor a symposium introducing OSSURE LOEP, a promising new minimally-invasive treatment to address osteoporotic bone loss in the proximal femur.
During the ASBMR (American Society for Bone Mineral Research) Annual Meeting in Colorado, US, Dr. Tony Keaveny, will deliver a lecture on the FEA of QCT scans of osteoporotic proximal femurs of participants in the COPLEY clinical study.
Today, the STRONG clinical study began enrolling patients.
Prof Klaus Engelke will present data from AgNovos’ Copley study at the 21st annual IBDW in Banz (Germany).
During the 44th European Calcified Tissue Society congress in Salzburg, AgNovos will present a poster with the results of a preclinical study performed to evaluate the biological response to implantation of OSSURE in critical-sized defects and whether those responses were impacted by alendronate therapy.